Research and Development

Seattle, Wash., and Somerset N.J., (June 20, 2012)  — Frazier Healthcare and Catalent Pharma Solutions, Inc., today announced they have closed …

Julia Straker has been appointed head of strategic planning at medical communciations agency PAN Advertising.  Julia joins from TBWA\Paling Walters …

Sanofi and the Joslin Diabetes Center have created a new partnership to develop diabetes medicines. The collaboration will focus on …

Quintiles sets up Chinese HQ, plus updates from BMS/Scripps, Metanomics Health, Inclinix/PMG and Tergus Pharma.

European regulators have issued final guidance on how pharma manufacturers should develop drugs containing monoclonal antibodies. Typically used in treatments …

The subsidiary of Merck KGaA named EMD Serono has announced several appointments to its leadership team. The appointments include: Allene …

Roche has signed an agreement with Seaside Therapeutics to develop new treatments for autism and other neurodevelopmental conditions such as …

The recent Westminster Health Forum meeting on ‘Developing Clinical Senates and Networks’ focused on one aspect of the new NHS …

HORSHAM, UK — June 18, 2012 – Cmed Clinical Services, the global CRO specialised in the design and delivery of …

The FDA has sent Pfizer a Complete Response Letter about its rare disease drug tafamidis meglumine. The US regulator is …

The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …

Merck’s novel insomnia drug suvorexant has improved patients’ ability to fall asleep, according to new data from two Phase III …

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

Professor Jonathan Montgomery will head up the Health Research Authority, the new organisation that will protect and promote the interests …

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …